Home | Publications | Dietary place holder
place holder place holder

Dietary

Vitamins and Dietary Supplements in Demark


Publication Date   November 2007
Publisher   Euromonitor International
Product Type   Report
Pages   31
ISBN Number   not applicable
Product Code   EUR915
Ask a question about this product?

Price £450.00

approximately: $795 | €571

Summary


Euromonitor International's Vitamins and Dietary Supplements in Finland report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data (2001-2006), allowing you to identify the sectors driving growth. It identifies the leading companies, the leading brands and offers strategic analysis of key factors influencing the market - be they new product developments, distribution or pricing issues. Forecasts to 2011 illustrate how the market is set to change.

Product coverage: vitamins, dietary supplements, tonics and bottled nutritive drinks, child-specific vitamins and dietary supplements

Data coverage: market sizes (historic and forecasts), company shares and brand shares.

Why buy this report?

  • Get a detailed picture of the vitamins and dietary supplements industry;
  • Pinpoint growth sectors and identify factors driving change;
  • Understand the competitive environment, the market's major players and leading brands;
  • Use five-year forecasts to assess how the market is predicted to develop.

Euromonitor International has over 30 years experience of publishing market research reports, business reference books and online information systems. With offices in London, Chicago, Singapore, Shanghai and Vilnius and a network of over 600 analysts worldwide, Euromonitor has a unique capability to develop reliable information resources to help drive informed strategic planning.

Content


OTC Healthcare - Russia

OTC Healthcare in Russia : Market Insight

EXECUTIVE SUMMARY
Health Standards Remain Low but Improve NRT Smoking Cessation Aids Dynamic but from Low Base Fragmented Sales Led by Multinationals Consumers Prefer Specialised Distribution Outlets Faster Growth in Forecast Period KEY TRENDS AND DEVELOPMENTS
Growing State Funding Supports Increased Sales Rx Medicines Still Dominate Competition from Homeopathy Intensifies Counterfeiting Still Huge but Losing Appeal Rising Foreign Investment Results in More Consolidated Shares Chained Chemists/Pharmacies Increasingly Significant CITY KEY TRENDS AND DEVELOPMENTS
Moscow St Petersburg MARKET INDICATORS
Table 1 Life Expectancy at Birth 2001-2006
MARKET DATA
Table 2 Sales of OTC Healthcare by Sector: Value 2001-2006
Table 3 Sales of OTC Healthcare by Sector: % Value Growth 2001-2006
Table 4 Sales of OTC Healthcare by City: Value 2001-2006
Table 5 Sales of OTC Healthcare by City: % Value Growth 2001-2006
Table 6 OTC Healthcare Company Shares by Retail Value 2002-2006
Table 7 OTC Healthcare Brand Shares by Retail Value 2003-2006
Table 8 Sales of OTC Healthcare by Distribution Format: % Analysis 2001/2006
Table 9 Sales of OTC Healthcare by Sector and Distribution Format: % Analysis 2006
Table 10 Forecast Sales of OTC Healthcare by Sector: Value 2006-2011
Table 11 Forecast Sales of OTC Healthcare by Sector: % Value Growth 2006-2011
Table 12 Forecast Sales of OTC Healthcare by City: Value 2006-2011
Table 13 Forecast Sales of OTC Healthcare by City: % Value Growth 2006-2011
APPENDIX
OTC Registration and Classification De-listing or De-reimbursement Advertising Packaging and Labelling Distribution Vitamins and Dietary Supplements Registration and Classification Generics Consumer Expenditure on Health Goods and Medical Services
Table 14 Consumer Expenditure on Health Goods and Medical Services 2001-2006
DEFINITIONS
Sources
Summary 1 Research Sources

Local Company Profiles - Russia

Akrikhin OAO - OTC Healthcare - Russia
STRATEGIC DIRECTION KEY FACTS
Summary 2 Akrikhin OAO: Key Facts
Summary 3 Akrikhin OAO: Operational Indicators 2004-2006
COMPANY BACKGROUND PRODUCTION COMPETITIVE POSITIONING
Summary 4 Akrikhin OAO: Competitive Position 2006
Evalar ZAO - OTC Healthcare - Russia
STRATEGIC DIRECTION KEY FACTS
Summary 5 Evalar ZAO: Key Facts
Summary 6 Evalar ZAO: Operational Indicators
COMPANY BACKGROUND PRODUCTION
Summary 7 Evalar ZAO: Production Statistics 2006
COMPETITIVE POSITIONING
Summary 8 Evalar ZAO: Competitive Position 2006
Krka Pharma OOO - OTC Healthcare - Russia
STRATEGIC DIRECTION KEY FACTS
Summary 9 Krka Pharma OOO: Key Facts
Summary 10 Krka dd/ Krka Pharma OOO: Operational Indicators 2006
COMPANY BACKGROUND PRODUCTION COMPETITIVE POSITIONING
Summary 11 Krka Pharma OOO: Competitive Position 2006
NaturProdukt Europe BV - OTC Healthcare - Russia
STRATEGIC DIRECTION KEY FACTS
Summary 12 NaturProdukt Europe BV: Key Facts
Summary 13 NaturProdukt Europe BV: Operational Indicators 2004-2005
COMPANY BACKGROUND PRODUCTION COMPETITIVE POSITIONING
Summary 14 NaturProdukt Europe BV: Competitive Position 2006
Nizhpharm AO - OTC Healthcare - Russia
STRATEGIC DIRECTION KEY FACTS
Summary 15 Nizhpharm OAO: Key Facts
Summary 16 Nizhpharm OAO: Operational Indicators 2004-2006
COMPANY BACKGROUND PRODUCTION COMPETITIVE POSITIONING
Summary 17 Nizhpharm OAO: Competitive Position 2006
Otechestvennye Lekarstva Group - OTC Healthcare - Russia
STRATEGIC DIRECTION KEY FACTS
Summary 18 Otechestvennye Lekarstva Group: Key Facts
Summary 19 Otechestvennye Lekarstva Group: Operational Indicators 2005-2006
COMPANY BACKGROUND PRODUCTION COMPETITIVE POSITIONING
Summary 20 Schelkovsky Vitaminy Zavod: Competitive Position 2006
Summary 21 Novosibkhimpharm AOOT: Competitive Position 2006
Pharmstandard Group - OTC Healthcare - Russia
STRATEGIC DIRECTION KEY FACTS
Summary 22 Pharmstandard Group: Key Facts
Summary 23 Pharmstandard Group: Operational Indicators 2004-2006
COMPANY BACKGROUND PRODUCTION
Summary 24 Pharmstandard Group: Production Statistics 2006
COMPETITIVE POSITIONING
Summary 25 Pharmstandard Group: Competitive Position 2006
Ranbaxy Laboratories Ltd - OTC Healthcare - Russia
STRATEGIC DIRECTION KEY FACTS
Summary 26 Ranbaxy Laboratories limited: Key Facts
Summary 27 Ranbaxy Laboratories limited: Operational Indicators 2004-2006
COMPANY BACKGROUND PRODUCTION COMPETITIVE POSITIONING
Summary 28 Ranbaxy Laboratories Ltd: Competitive Position 2006
Veropharm ZAO - OTC Healthcare - Russia
STRATEGIC DIRECTION KEY FACTS
Summary 29 Veropharm ZAO: Key Facts
Summary 30 Veropharm ZAO: Operational Indicators 2004-2006
COMPANY BACKGROUND PRODUCTION
Summary 31 Veropharm ZAO: Production Statistics 2006
COMPETITIVE POSITIONING
Summary 32 Veropharm ZAO: Competitive Position 2006

Analgesics in Russia

HEADLINES
TRENDS
COMPETITIVE LANDSCAPE
PROSPECTS
SECTOR DATA
Table 15 Sales of Analgesics by Subsector: Value 2001-2006
Table 16 Sales of Analgesics by Subsector: % Value Growth 2001-2006
Table 17 Herbal vs Standard Topical Analgesics 2001/2006
Table 18 Analgesics Company Shares by Retail Value 2002-2006
Table 19 Analgesics Brand Shares by Retail Value 2003-2006
Table 20 Forecast Sales of Analgesics by Subsector: Value 2006-2011
Table 21 Forecast Sales of Analgesics by Subsector: % Value Growth 2006-2011